title: Genetic variants of SDF-1 and CXCR4 genes in endometrial carcinoma.
abstract: In this study, we aimed to investigate a possible association between the Stromal cell-derived factor-1 (SDF-1) and CXCR4 polymorphisms and the risk of developing endometrial carcinoma. SDF-1 3'A and CXCR4 gene polymorphisms was performed by polymerase chain reaction (PCR) and restriction fragment length polymorphism in 139 healthy individuals and 113 patients with endometrial carcinoma. In our study groups SDF-1 3'A AA genotype frequency was higher in patients that of controls and individuals who had AA genotype showed a 2.6-fold increased risk for endometrial cancer. The carriers of CXCR4 T allele were higher in patients compared with controls and individuals who had TT genotype had a 2.5-fold high risk for endometrial carcinoma. Our finding suggest that there was no significant association between the (SDF-1) and CXCR4 polymorphisms and endometrium cancer risk. Further studies in a larger population are needed to better elucidate the role of (SDF-1) and CXCR4 gene polymorphisms in the risk of endometrial carcinogenesis. To the best of our knowledge, this is the first study to show such an association.
authors: Department of Molecular Medicine, Institute of Experimental Medicine Research, Istanbul University, Vakif Gureba Cad. Capa, 34093 Istanbul, Turkey.
authors: Canan
authors: C
authors: Cacina
authors: Sibel
authors: S
authors: Bulgurcuoglu-Kuran
authors: Ahmet Cem
authors: AC
authors: Iyibozkurt
authors: Ilhan
authors: I
authors: Yaylim-Eraltan
authors: Bedia
authors: B
authors: Cakmakoglu
references: Semin Immunol. 2003 Feb;15(1):49-55
references: 12495640
references: J Clin Lab Anal. 2009;23(6):387-93
references: 19927352
references: Science. 1998 Jan 16;279(5349):389-93
references: 9430590
references: Semin Cancer Biol. 2004 Jun;14(3):181-5
references: 15246053
references: Nucleic Acids Res. 1988 Feb 11;16(3):1215
references: 3344216
references: Cancer Lett. 2005 Jul 28;225(2):261-6
references: 15978329
references: Curr Opin Pharmacol. 2009 Aug;9(4):351-69
references: 19665429
references: J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S460-75
references: 12592293
references: J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):521-6
references: 16284526
references: Genomics. 1995 Aug 10;28(3):495-500
references: 7490086
references: Pathol Oncol Res. 2008 Mar;14(1):45-50
references: 18386165
references: Semin Cancer Biol. 2004 Jun;14(3):195-200
references: 15246055
references: Mol Biol Rep. 2010 Oct;37(7):3421-6
references: 19941075
references: Annu Rev Genomics Hum Genet. 2002;3:263-92
references: 12142357
references: Ann N Y Acad Sci. 2004 Dec;1037:79-83
references: 15699497
references: Braz J Infect Dis. 2010 Mar-Apr;14(2):197-200
references: 20563451
references: Mol Biol Rep. 2010 Jan;37(1):399-403
references: 19821058
references: Mol Biol Rep. 2010 Oct;37(7):3615-9
references: 20182805
references: Cancer Res. 2002 Nov 1;62(21):6304-11
references: 12414661
references: Pathol Oncol Res. 2010 Jun;16(2):223-7
references: 19834823
references: Genomics. 1993 Jun;16(3):707-12
references: 8325644
references: Postepy Hig Med Dosw (Online). 2008 Aug 18;62:420-32
references: 18772847
references: Annu Rev Med. 1999;50:425-40
references: 10073287
references: Blood Cells Mol Dis. 2004 Jul-Aug;33(1):90-3
references: 15223017
references: Cancer Immunol Immunother. 2006 Jun;55(6):639-43
references: 16155757
references: Clin Cancer Res. 2007 Sep 1;13(17):5056-62
references: 17785557
references: Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):227-51
references: 16543119
references: Microb Pathog. 2003 Jul;35(1):31-4
references: 12860456
references: Clin Chem Lab Med. 2009;47(4):412-8
references: 19327121
references: Cancer Lett. 2004 Oct 28;214(2):231-41
references: 15363550
references: Head Neck. 2009 Oct;31(10):1282-8
references: 19373784
references: Lung Cancer. 2005 Sep;49(3):311-5
references: 15955592
references: Anticancer Res. 2008 Jan-Feb;28(1A):271-5
references: 18383856